Small cell lung cancer (SCLC) is characterized by rapid growth and high metastatic capacity.
It has strong epidemiologic and biologic links to tobacco carcinogens. Although the majority …

Lung cancer is one of the most aggressive and deadliest health threats. There has been an
increasing interest in non-coding RNA (ncRNA) recently, especially in the areas of …

One major challenge associated with lung cancer organoids (LCOs) is their predominant
derivation from surgical specimens of patients with early-stage lung cancer. However …

Respiratory tissue engineering offers a robust framework for studying cell-cell and host-
pathogen interactions in a tissue-like environment and offers a platform for studying lung …

Moving toward precision medicine with lung cancer organoids Page 1 Preview Moving
toward precision medicine with lung cancer organoids James Kim1,2,4,* and John D. Minna1,2,3,4 …

Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancer subtypes,
with a grave prognosis and few effective treatment options. Organoids represent …

Small Cell Lung Cancer (SCLC) is an extremely aggressive form of cancer, accounting for
about 15% of all lung cancer cases. Due to its aggressive nature, over 60% of SCLC cases …

Simple Summary The lack of models capable of reproducing the cellular mechanisms
responsible for cancer progression in vivo makes it difficult to develop effective anticancer …

This work describes a patient-derived tumoroid model (PDTs) to support precision medicine
in lung oncology. The use of human adipose tissue-derived microvasculature and patient …

Simple Summary Zebrafish is a crucial in vivo model for lung cancer research and is widely
employed in studies focusing on cancer proliferation, metastasis, and angiogenesis. It plays …